Eric Fujimura
Brigham and Women's Hospital
5 Papers
Eric Fujimura is an academic researcher from Brigham and Women's Hospital. The author has contributed to research in topics: Antibody & Epitope. The author has an hindex of 3, co-authored 3 publications. Previous affiliations of Eric Fujimura include Harvard University.
Chat about Author
Papers
Viral epitope profiling of COVID-19 patients reveals cross-reactivity and correlates of severity.
Ellen Shrock,Ellen Shrock,Eric Fujimura,Eric Fujimura,Tomasz Kula,Tomasz Kula,Richard T. Timms,Richard T. Timms,I-Hsiu Lee,Yumei Leng,Yumei Leng,Matthew L Robinson,Brandon M. Sie,Brandon M. Sie,Mamie Z. Li,Mamie Z. Li,Yuezhou Chen,Jennifer K. Logue,Adam Zuiani,Denise J. McCulloch,Felipe J.N. Lelis,Stephanie A. Henson,Daniel R. Monaco,Meghan Travers,Shaghayegh Habibi,William Clarke,Patrizio Caturegli,Oliver Laeyendecker,Oliver Laeyendecker,Alicja Piechocka-Trocha,Jonathan Z. Li,Ashok Khatri,Helen Y. Chu,Alexandra-Chloé Villani,Kyle R. Kays,Marcia B. Goldberg,Nir Hacohen,Michael R. Filbin,Xu G. Yu,Bruce D. Walker,Bruce D. Walker,Duane R. Wesemann,H. Benjamin Larman,James A. Lederer,Stephen J. Elledge,Stephen J. Elledge +45 more
TL;DR: A systematic characterization of the humoral response to severe acute respiratory system coronavirus 2 (SARS-CoV-2) epitopes has yet to be performed, important for understanding the immunogenicity of the viral proteome and the basis for cross-reactivity with the common-cold coronaviruses.
678
Antibody responses to endemic coronaviruses modulate COVID-19 convalescent plasma functionality.
William R. Morgenlander,Stephanie N. Henson,Daniel R. Monaco,Athena Chen,Kirsten Littlefield,Evan M. Bloch,Eric Fujimura,Ingo Ruczinski,Andrew R. Crowley,Harini Natarajan,Savannah E. Butler,Joshua A. Weiner,Mamie Z. Li,Tania S. Bonny,Sarah E. Benner,Ashwin Balagopal,David Sullivan,David Sullivan,Shmuel Shoham,Thomas C. Quinn,Thomas C. Quinn,Susan H. Eshleman,Arturo Casadevall,Andrew D. Redd,Andrew D. Redd,Oliver Laeyendecker,Oliver Laeyendecker,Margaret E. Ackerman,Andrew Pekosz,Stephen J. Elledge,Matthew L Robinson,Aaron A.R. Tobian,H. Benjamin Larman +32 more
TL;DR: In this article, the authors assessed antibody functionality and reactivities to peptides across the CoV2 and the 4 endemic human coronavirus (HCoV) genomes in 126 CCP donations.
Germline-encoded amino acid-binding motifs drive immunodominant public antibody responses
Ellen Shrock,Richard T. Timms,Tomasz Kula,Elijah L. Mena,Anthony P. West,Rui Guo,I-Hsiu Lee,Alexander A. Cohen,Lindsay McKay,Caihong Bi,Keerti,Yumei Leng,Eric Fujimura,Felix Horns,Mamie Z. Li,Duane R. Wesemann,Anthony Griffiths,Benjamin E. Gewurz,Pamela J. Bjorkman,Stephen J Elledge +19 more
TL;DR: Shrock et al. as discussed by the authors used a phage display platform called VirScan to identify the epitopes of antiviral antibodies from a large cohort of individuals in a high-throughput manner.
54
Genetic analysis of cancer drivers reveals cohesin and CTCF as suppressors of PD-L1
Ena Oreskovic,Emily C. Wheeler,Kristen E. Mengwasser,Eric Fujimura,Timothy D. Martin,Zuzana Tothova,Stephen J. Elledge +6 more
TL;DR: Discovery of the PD-L1 and IFN up-regulation in cohesin-mutant cells expands the understanding of the biology of cohes in-deficient cells as well as molecular regulation of thePD-L 1 molecule.
23
Antibody responses to endemic coronaviruses modulate COVID-19 convalescent plasma functionality
William R. Morgenlander,Stephanie N. Henson,Daniel R. Monaco,Athena Chen,Kirsten Littlefield,Evan M. Bloch,Eric Fujimura,Ingo Ruczinski,Andrew R. Crowley,Harini Natarajan,Savannah E. Butler,Joshua A. Weiner,Mamie Z. Li,Tania S. Bonny,Sarah E. Benner,Ashwin Balagopal,David Sullivan,David Sullivan,Shmuel Shoham,Thomas C. Quinn,Thomas C. Quinn,Susan H. Eshleman,Arturo Casadevall,Andrew D. Redd,Andrew D. Redd,Oliver Laeyendecker,Oliver Laeyendecker,Margaret E. Ackerman,Andrew Pekosz,Stephen J. Elledge,Matthew L Robinson,Aaron A.R. Tobian,H. Benjamin Larman +32 more
TL;DR: Analysis of coronavirus antibody fine specificities may be useful for selecting therapeutic plasma with desired functionalities for COVID-19 convalescent plasma donations.